Advertisement
ENOV vs ZBH
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENOV is a Buy and ZBH is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ENOV’s FA Score shows that 0 FA rating(s) are green whileZBH’s FA Score has 0 green FA rating(s).
- ENOV’s FA Score: 0 green, 5 red.
- ZBH’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ENOV’s TA Score shows that 5 TA indicator(s) are bullish while ZBH’s TA Score has 4 bullish TA indicator(s).
- ENOV’s TA Score: 5 bullish, 2 bearish.
- ZBH’s TA Score: 4 bullish, 4 bearish.
Price Growth
ENOV (@Medical/Nursing Services) experienced а +2.99% price change this week, while ZBH (@Medical/Nursing Services) price change was -3.58% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.11%. For the same industry, the average monthly price growth was +6.44%, and the average quarterly price growth was +6.99%.
Reported Earning Dates
ENOV is expected to report earnings on Oct 30, 2025.
ZBH is expected to report earnings on Oct 29, 2025.
Industries' Descriptions
@Medical/Nursing Services (+2.11% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| ENOV | ZBH | ENOV / ZBH | |
| Capitalization | 1.85B | 20B | 9% |
| EBITDA | -472.1M | 2.28B | -21% |
| Gain YTD | -26.299 | -3.968 | 663% |
| P/E Ratio | N/A | 24.62 | - |
| Revenue | 2.19B | 7.83B | 28% |
| Total Cash | 44.1M | 557M | 8% |
| Total Debt | 1.47B | 7.57B | 19% |
ENOV | ZBH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 67 | 57 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 79 Overvalued | 44 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 97 | 80 | |
PRICE GROWTH RATING 1..100 | 61 | 55 | |
P/E GROWTH RATING 1..100 | 98 | 36 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ZBH's Valuation (44) in the Medical Specialties industry is somewhat better than the same rating for ENOV (79) in the Industrial Machinery industry. This means that ZBH’s stock grew somewhat faster than ENOV’s over the last 12 months.
ZBH's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ENOV (100) in the Industrial Machinery industry. This means that ZBH’s stock grew similarly to ENOV’s over the last 12 months.
ZBH's SMR Rating (80) in the Medical Specialties industry is in the same range as ENOV (97) in the Industrial Machinery industry. This means that ZBH’s stock grew similarly to ENOV’s over the last 12 months.
ZBH's Price Growth Rating (55) in the Medical Specialties industry is in the same range as ENOV (61) in the Industrial Machinery industry. This means that ZBH’s stock grew similarly to ENOV’s over the last 12 months.
ZBH's P/E Growth Rating (36) in the Medical Specialties industry is somewhat better than the same rating for ENOV (98) in the Industrial Machinery industry. This means that ZBH’s stock grew somewhat faster than ENOV’s over the last 12 months.
| ENOV | ZBH | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 53% |
| Stochastic ODDS (%) | 1 day ago 72% | 1 day ago 68% |
| Momentum ODDS (%) | 1 day ago 64% | 1 day ago 57% |
| MACD ODDS (%) | N/A | 1 day ago 60% |
| TrendWeek ODDS (%) | 1 day ago 65% | 1 day ago 56% |
| TrendMonth ODDS (%) | 1 day ago 63% | 1 day ago 55% |
| Advances ODDS (%) | 1 day ago 62% | 28 days ago 63% |
| Declines ODDS (%) | 7 days ago 74% | 1 day ago 56% |
| BollingerBands ODDS (%) | N/A | 1 day ago 61% |
| Aroon ODDS (%) | 1 day ago 55% | 1 day ago 54% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RFIX | 43.83 | 0.49 | +1.13% |
| Simplify Downside Interest Rate Hedge Strategy ETF | |||
| NBH | 10.44 | 0.05 | +0.48% |
| Neuberger Berman Municipal Fund | |||
| AMUB | 18.88 | N/A | N/A |
| UBS ETRACS Alerian MLP ETN Series B | |||
| WRND | 35.51 | N/A | N/A |
| NYLI Global Equity R&D Leaders ETF | |||
| FLQM | 56.75 | -0.39 | -0.68% |
| Franklin US Mid Cap Mltfctr Idx ETF | |||
ENOV and
Correlation & Price change
A.I.dvisor indicates that over the last year, ENOV has been loosely correlated with CNMD. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ENOV jumps, then CNMD could also see price increases.
| Ticker / NAME | Correlation To ENOV | 1D Price Change % | ||
|---|---|---|---|---|
| ENOV | 100% | +1.95% | ||
| CNMD - ENOV | 59% Loosely correlated | -1.73% | ||
| IART - ENOV | 59% Loosely correlated | +0.07% | ||
| FELE - ENOV | 56% Loosely correlated | -0.06% | ||
| DOV - ENOV | 55% Loosely correlated | -0.60% | ||
| ITGR - ENOV | 54% Loosely correlated | -1.13% | ||
More | ||||